Improving cervical cancer screening and follow-up for underserved populations
Official title: Development of Systems and Education for Cervical Cancer prevention (DOSE-CC)
Funded at Boston Medical Center · NIH-11099295 · Data updated 2026-11-12
This study is working to make cervical cancer screening easier and more effective for underserved communities, like urban Black and Haitian populations, Hispanic immigrants, and Hawaiian Natives, by using a proven method that combines education and support for healthcare providers.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Boston Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project start | May 1, 2025 |
| Project end | April 30, 2030 |
| Funding year | 2025 |
| Award (this year) | $753,446 |
| NIH project number | 1R01CA299475-01 |
| Project ID | NIH-11099295 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include Black, Hispanic, and low-income individuals who are at risk for cervical cancer and have not been screened in the past five years.
✕Less likely to help
Patients who have been regularly screened for cervical cancer or those who do not belong to the targeted underserved populations may not benefit from this research.
What this research studies
This research aims to enhance cervical cancer screening and follow-up among underserved populations, particularly focusing on urban inner city Blacks/Haitians, Hispanic immigrants, and Hawaiian Natives/Pacific Islanders. The approach involves adapting a previously successful intervention that improved HPV vaccination rates by combining education with quality improvement methods. The intervention will be tested in diverse communities to ensure it effectively addresses barriers to screening and follow-up. By engaging healthcare providers through Performance Improvement Continuing Medical Education, the project seeks to improve cancer prevention practices while meeting certification requirements.
Why it matters
Potential benefit: If successful, this research could significantly increase cervical cancer screening rates and reduce health disparities among vulnerable populations.
How similar studies have gone: Previous research has shown success in improving HPV vaccination rates using similar educational and quality improvement interventions.
Where this research is happening
-
Boston Medical Center
Boston, United States Active
Researchers
- Principal investigator: Lunze, Karsten — Boston Medical Center
- Study coordinator: Lunze, Karsten
Related research
Other NIH-funded projects on the same topics.
-
Community and digital tools to reduce HPV and cervical cancer burden
A nurse or health team will test a community-based, digital strategy to help girls and young women, especially in rural areas, get HPV vaccination and cervical cancer prevention services.
-
Community and digital tools to reduce HPV and cervical cancer in women with HIV
A community- and digital-technology program aims to help girls and young women, including those with HIV, get more HPV vaccination and cervical cancer prevention services.
-
mSaada: a mobile tool to boost cervical cancer screening in western Kenya
A mobile app helps community health volunteers manage cervical cancer screening tasks and follow-up for women in low-resource areas.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
HPV self-collection in HIV care to screen for cervical cancer in Ethiopia
A patient-centered program tests a simple HPV self-collection approach within HIV clinics in Ethiopia to help detect cervical cancer earlier.
-
Hybrid approach to boost cervical cancer screening in Uganda
A tested, community-driven program helps Ugandan women encourage their peers to get free VIA cervical cancer screening.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.